ARTICLE | Company News
Cambridge Centre for Protein Engineering other research news
November 3, 1997 8:00 AM UTC
Cambridge Centre scientists and colleagues published in Nature Biotechnology the use of antibody fragments against the oncofetal isoform of fibronectin (B- FN) to image cancer in vivo. B-FN is an extracellular matrix protein expressed in cancer tissue during tumor angiogenesis but not in mature blood vessels. The antibodies were used to image solid teratocarcinoma tumors grafted into mice. ...